Restoring Cellular Resilience
to Conquer Disease

About Us

Fountain’s mission is to develop a pipeline of therapeutics that treat the underlying cause of degenerative diseases by utilizing our breakthroughs in artificial intelligence and computational modeling to target the biology of cellular resilience.

Our AI-driven platform identifies previously hidden cellular features to model cellular resilience with remarkable precision. This has enabled us to generate unprecedented insights into the cellular aging process. We have united science, engineering, and medicine to turn these insights and technologies into a powerful drug discovery and development engine for the treatment of age-related chronic degenerative diseases.

Aging and Health

Aging is the predominant challenge to our health and quality of life.

Cellular aging shares similar biological pathways with many other physiological processes in our body. This provides us with an opportunity for therapeutic intervention to ameliorate many chronic degenerative diseases. At Fountain, we are dedicated to developing therapeutics to target cellular resilience as a new way to treat the many diseases that arise from aging.

Fountain Team

Fountain is comprised of an exceptional team of scientists, engineers, physicians, drug developers, entrepreneurs, and visionaries who see the path to a healthier future. Our team members work in unison combining their expertise in aging biology and machine learning to achieve our mission to develop novel therapeutics to treat chronic degenerative diseases.

Management

Thomas Rando

Thomas Rando, M.D., Ph.D.

Co-Founder,
Executive Chairman,
Board of Directors

View Bio
Anupama Hoey, M.Sc., M.B.A.

Anupama Hoey, M.Sc., M.B.A.

Chief Operating and Business Officer,
Board Member

View Bio
Joe Rodgers

Joseph Rodgers, Ph.D.

Co-Founder,
Director of Biology

View Bio
Joe Rodgers

Joseph Rodgers, Ph.D.

Co-Founder,
Director of Biology

View Bio
Tom Cheung

Tom Cheung, Ph.D.

Co-Founder

View Bio
Tom Cheung

Tom Cheung, Ph.D.

Co-Founder

View Bio

Our Investors

Recent News

Fountain Therapeutics Announces Appointment of Anupama Hoey as Chief Business Officer

Fountain Therapeutics Announces $15 Million Series A-2 Financing

Fountain Therapeutics to Present at 2nd Annual LifeSci Partners Private Company Summer Symposium

Fountain Therapeutics Appoints William L. Greene, M.D. Chief Executive Officer

Scrip Asks…What Does 2021 Hold For Biopharma? Part 4: Technology And Disease

Biopharma Executive Perspectives on 2021

A year in Longevity: science perspectives

View From The Inside: What’s Shaping Biopharma In 2021 And Beyond?

HQ Move Fuels Fountain’s AI Drug Discovery Machine

SMA, NMOSD and Aging – From Few to EveryoneOctober 14, 2020 Radio show

Fountain Therapeutics Moves Corporate Headquarters to Lilly Gateway Labs in South San Francisco

Healthy aging – it’s still all about diet and exercise. For now

Intervening in the Aging Process to Treat Age-Associated Diseases with John Dimos Fountain Therapeutics

Targeting Diseases of Aging at a Cellular Level

Fountain Therapeutics: an AI-based platform to reverse cellular aging

Hiring During COVID-19: Business as Usual in the New Normal

Biotech Startups Look to Test Employees for Covid-19 in Bid to Get Back to Normal

Fountain’s ‘hypothesis-free’ approach to Longevity AI

Fountain Therapeutics Closes $6 Million Series A-1 Financing

Fountain fires up aging drugs platform with new $6M financing

Four medical school professors elected to American Academy of Arts and Sciences

Join Our Team

We are looking for fellow scientists, engineers and entrepreneurs who share our mission of building a new path forward to improve the length of quality life.

Interested in becoming part of our growing team passionate for innovation, technology and aging research?
Reach out to us: careers@fountaintx.com.

Contact Us

We are here to answer any questions you may have about Fountain including our technology and business objectives. Looking to invest in us or exploring a partnering opportunity? Reach out to us:

Scroll to Top